Cajal Neuroscience Inc. 
1150 Eastlake Ave E, Ste 600/700. 
Seattle, WA 98109.

Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

LinkedIn

Twitter

Cajal Neuroscience and Creyon Bio Announce Partnership to Develop Oligonucleotide-Based Medicines for Neurodegenerative Diseases

Cajal Comes Out of Stealth with $96M for Alzheimer's, Parkinson's Drug Discovery

Cajal Neuroscience Launches with $96 Million to Transform Target and Drug Discovery in Neurodegeneration

Seattle startup with fresh approach to Parkinson’s and Alzheimer’s disease raises $96M